Muhammet Mucahit Tiryaki

Dr. Muhammet Mucahit Tiryaki

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 December 2024 in Biomarkers in Medicine
Verified
Journal Article
Closed access
CYCemalettin Yılmaz
Cemalettin Yılmaz
AKAhmet Karaduman
Ahmet Karaduman
MTMuhammet Mucahit Tiryaki
Muhammet Mucahit Tiryaki
BSBusra Guvendi Sengor
Busra Guvendi Sengor
TUTuba Unkun
Tuba Unkun
RZRegayip Zehir
Regayip Zehir
No-reflow is a critical adverse event associated with percutaneous coronary intervention (PCI), particularly during saphenous vein graft (SVG) procedures. The Naples Prognostic Score (NPS) reflects inflammatory status, but its relationship with no-reflow remains unclear. Therefore, we aimed to evaluate the relationship between NPS and no-reflow occurrence following SVG PCI. We retrospectively analyzed 286 patients who underwent SVG PCI from January 2020 to January 2024, with a median age of 65 years and 85.7% male. Participants were categorized into low NPS (0-2, 48.6%) and high NPS (3-4, 51.4%) groups. Two nested models were developed by adding NPS (continuous and categorical, respectively) to the base model. Higher no-reflow rates were noted in the high-NPS group (48.5% vs. 9.5%, p < 0.05). Multivariable regression revealed that a higher NPS significantly increased no-reflow risk, with odds ratios of 5.966 (95% CI: 3.066-11.611) for continuous NPS and 10.110 (95% CI: 3.194-32.002) for categorical NPS. Adding NPS to the base model significantly improved predictive performance (likelihood-ratio test p < 0.001). Model 1 demonstrated the best performance (X2 : 84.857, R2 : 0.468) and discriminative ability (AUC: 0.888). Our findings suggest that NPS is a strong predictor of no-reflow following SVG PCI.

21 October 2024 in Biomarkers in Medicine
Verified
Journal Article
Closed access
AKAhmet Karaduman
Ahmet Karaduman
CYCemalettin Yılmaz
Cemalettin Yılmaz
MKMustafa Ferhat Keten
Mustafa Ferhat Keten
İBİsmail Balaban
İsmail Balaban
BKBarkın Kültürsay
Barkın Kültürsay
RZRegayip Zehir
Regayip Zehir
Aim: This study aimed long-term prognostic factors for percutaneous coronary intervention (PCI) in left main coronary artery (LMCA) disease, focusing on inflammatory parameters like Pan Immune-Inflammation Value (PIV) and Systemic Immune-Inflammation Index (SII).Materials & methods: This retrospective, observational study involved 121 patients receiving unprotected LMCA PCI.The study's primary end point was MACE, including all-cause death, repeat revascularization and myocardial reinfarction.Results: The PIV and SII scores emerged as independent predictors of MACE occurrence in patients undergoing PCI for unprotected LMCA disease (p:0.045,p:0.048;respectively).In addition, age, ejection fraction, creatinine, shock presentation and the residual syntax score were identified as significant independent predictors of MACE in both models.Conclusion: This study showed a significant, independent correlation between PIV, SII and MACE in patients undergoing PCI for LMCA disease, with PIV showing slightly better predictive capability than SII.

1 January 2025 in Arquivos Brasileiros de Cardiologia
Verified
Journal Article
Open access
PDF file
AKAhmet Karaduman
Ahmet Karaduman
CYCemalettin Yılmaz
Cemalettin Yılmaz
MTMuhammet Mucahit Tiryaki
Muhammet Mucahit Tiryaki
IBİsMail Balaban
İsMail Balaban
MKMustafa Ferhat Keten
Mustafa Ferhat Keten
EAElnur Alizade
Elnur Alizade
Background Saphenous vein graft (SVG) patency remains a challenge in cases of coronary artery disease following coronary artery bypass grafting (CABG) surgery. The Naples prognostic score (NPS) constitutes a novel scoring system designed to assess both nutritional status and inflammation. Objectives Our study aimed to explore the association between the NPS and SVG disease in patients with a previous history of CABG surgery. Methods A total of 702 patients who had undergone CABG surgery and underwent coronary angiography were reviewed retrospectively. SVG disease was defined as the presence of ≥50% stenosis in at least one SVG. Patients were categorized into two groups based on the presence or absence of SVG disease. Values of p<0.05 were accepted as statistically significant. Results The study population consisted of 702 patients, with 269 (38.3%) having degenerative SVGs and 433 (61.7%) without degenerative SVGs. The NPS was higher in the group with saphenous vein degeneration and emerged as a significant predictor of SVG disease (OR: 1.596, 95% CI: 1.198-2.125, p=0.001). Additionally, hypertension (OR: 2.344, 95% CI: 1.137-4.833, p=0.02), chronic kidney disease (OR: 3.337, 95% CI: 1.554-7.168, p=0.002), statin usage (OR: 0.434, 95% CI: 0.239-0.789, p=0.006), time interval since CABG (OR: 1.138, 95% CI: 1.213-1.432, p<0.001), and number of SVGs (OR: 2.708, 95% CI: 1.902-3.855, p<0.001) were significant predictors of SVG disease. Conclusion The NPS, a useful tool for assessing inflammation and nutritional status, could provide valuable information about the patency of SVGs following CABG surgery. Patients with elevated NPS after CABG should undergo careful monitoring for the development of SVG disease.

1 January 2025 in Arquivos Brasileiros de Cardiologia
Verified
Journal Article
Open access
PDF file
AKAhmet Karaduman
Ahmet Karaduman
CYCemalettin Yılmaz
Cemalettin Yılmaz
MTMuhammet Mucahit Tiryaki
Muhammet Mucahit Tiryaki
IBİsMail Balaban
İsMail Balaban
MKMustafa Ferhat Keten
Mustafa Ferhat Keten
EAElnur Alizade
Elnur Alizade
Resumo Fundamento A permeabilidade do enxerto de veia safena (EVS) continua sendo um desafio em casos de doença arterial coronária após cirurgia de revascularização do miocárdio (CRM). O escore prognóstico de Nápoles (NPS) constitui um novo sistema de pontuação projetado para avaliar tanto o estado nutricional quanto a inflamação. Objetivos Nosso estudo teve como objetivo explorar a associação entre NPS e doença do EVS em pacientes com histórico prévio de CRM. Métodos Foram revisados um total de 702 pacientes submetidos à CRM e à angiografia coronáriaretrospectivamente. A doença do EVS foi definida como a presença de estenose ≥50% em pelo menos um EVS. Os pacientes foram categorizados em dois grupos com base na presença ou ausência de doença do EVS. Valores de p<0,05 foram aceitos como estatisticamente significativos. Resultados A população do estudo consistiu em 702 pacientes, com 269 (38,3%) apresentando EVSs degenerativos e 433 (61,7%) sem EVSs degenerativos. O NPS foi maior no grupo com degeneração da veia safena e surgiu como um preditor significativo de doença do EVS (OR: 1,596, IC 95%: 1,198-2,125, p=0,001). Além disso, hipertensão (OR: 2,344, IC 95%: 1,137-4,833, p=0,02), doença renal crônica (OR: 3,337, IC 95%: 1,554-7,168, p=0,002), uso de estatina (OR: 0,434, IC 95%: 0,239-0,789, p=0,006), intervalo de tempo desde a CRM (OR: 1,138, IC 95%: 1,213-1,432, p<0,001) e número de EVSs (OR: 2,708, IC 95%: 1,902-3,855, p<0,001) foram preditores significativos da doença do EVS. Conclusão O NPS, uma ferramenta útil para avaliar inflamação e estado nutricional, pode fornecer informações valiosas sobre a permeabilidade de EVSs após cirurgia de CRM. Pacientes com NPS elevado após CRM devem passar por monitoramento cuidadoso para o desenvolvimento de doença de EVS.

27 December 2024 in Biomarkers
Verified
Journal Article
Closed access
CYCemalettin Yılmaz
Cemalettin Yılmaz
MTMuhammet Mucahit Tiryaki
Muhammet Mucahit Tiryaki
AKAhmet Karaduman
Ahmet Karaduman
BSBusra Guvendi Sengor
Busra Guvendi Sengor
TUTuba Unkun
Tuba Unkun
RZRegayip Zehir
Regayip Zehir
Mortality in patients after carotid artery stenting (CAS), a treatment approach for atherosclerotic carotid artery stenosis, is influenced by numerous factors. This study aimed to investigate the prognostic value of the Naples prognostic score (NPS), which reflects nutritional and inflammatory status, in CAS patients. We retrospectively included 697 patients who underwent CAS from January 2016 to December 2020 at our institute. The primary endpoint of the study was long-term all-cause mortality. The study population was divided into two groups based on the NPS value: low NPS (NPS 0-2) and high NPS (NPS 3-4). Univariable and multivariable Cox regression analysis was used to identify independent predictors of death. The median follow-up time was 60.8 (46.36-75.36) months. During the follow-up period, all-cause mortality was higher in the high-NPS group compared to the low-NPS group [54% (n = 88) vs. 24% (n = 128) p < 0.001]. Advanced age (p = 0.003), diabetes (p = 0.023), and NPS (hazard ratio: 1.83, confidence interval: 1.58-2.12, p < 0.001) were found to be independent predictors of all-cause mortality at long-term follow-up. Consequently, NPS as a marker of malnutrition and inflammation, was found to be associated with long-term mortality and serves as an independent predictor of long-term mortality in patients undergoing CAS.

27 June 2025 in Harran Üniversitesi Tıp Fakültesi Dergisi
Verified
Journal Article
Open access
PDF file
AKAhmet Karaduman
Ahmet Karaduman
CYCemalettin Yılmaz
Cemalettin Yılmaz
İBİsmail Balaban
İsmail Balaban
MKMustafa Ferhat Keten
Mustafa Ferhat Keten
MTMuhammet Mucahit Tiryaki
Muhammet Mucahit Tiryaki
EAElnur Alızade
Elnur Alızade
Background: Contrast-induced acute kidney injury (CI-AKI) can be a serious complication for patients with peripheral artery disease(PAD) undergoing peripheral vascular interventions(PVI). An interarm blood pressure difference (IABPD)≥10 mmHg has been identified as an independent risk factor for cardiovascular disease and mortality. This study aimed to evaluate the predictive value of IABPD for the risk of CI-AKI in PAD patients undergoing PVI. Materials and Methods: This prospective study included 171 consecutive patients who underwent PVI. IABPD was defined as the difference in systolic blood pressure between the two arms and was considered significant if it was≥10 mmHg. Patients were categorized into two groups based on the occurrence of CI-AKI. Results: The incidence of CI-AKI after PVI was 21 %. The CI-AKI(+) group had a significantly higher incidence of IABPD >10 mmHg (28% vs. 8%, p<0.001). Multivariable logistic regression analysis identified IABPD (OR:1.135, 95% CI:1.037-1.243, p=0.006) as an independent predictor of CI-AKI. Additionally, hypertension (OR:2.308, 95% CI:1.091-4.885, p=0.03), higher mean blood pressure (OR:1.055, 95% CI 1.001-1.111, p=0.04), lower eGFR (OR 0.963, 95% CI 0.948-0.978, p<0.001), higher CRP levels (OR:1.028, 95% CI:1.006-1.050, p=0.01), and lower LVEF (OR:0.969, 95% CI 0.938-0.998, p=0.04) were significant predictors of CI-AKI. Furthermore, having TASC C-D lesions compared to TASC A-B was associated with a higher risk of CI-AKI (OR:3.304, 95% CI 1.197-9.117, p=0.02). Conclusions: This study demonstrated that IABPD is significantly associated with the development of CI-AKI in patients undergoing PVI for PAD. Assessing IABPD in patients before PVI could help clinicians identify those at an elevated risk for developing CI-AKI. Keywords: Contrast-induced acute kidney injury, Interarm blood pressure difference, Peripheral artery dis-ease, Peripheral vascular intervention